- Email: [email protected]
Lisa D. Crockett has over 19 years in the pharmaceutical, biotechnology and medical device industries, and is a member of the Regulatory Affairs faculty. She is currently the Vice President, Regulatory Affairs and Reimbursement Planning at InVivo Therapeutics, a medical device company who is developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI) medical devices and combination products. She has also worked at Genzyme, a Sanofi Company supporting the development of medical devices & combination products in the orthopedic area in a global marketplace. Prior to joining Genzyme, Lisa worked at both V.I. Technologies (Vitex) and Biopure Corporation that focused on the development of biologics for oxygen-carrying solutions and viral inactivation of RBCs.
Lisa holds a MS in Regulatory Affairs from Northeastern University and BS in Equine Science from Johnson & Wales University. She has also received the U.S. Regulatory Affairs Certification (RAC) designation.